Randy Scott, Ph.D., Chairman and CEO of Genomic Health, Inc.,
Rings The NASDAQ Stock Market Closing Bell

Wednesday, February 15, 2006
at NASDAQ's MarketSite
in New York City.

Genomic Health, Inc.

Randy Scott, Ph.D., Chairman and CEO of Genomic Health, Inc., presides over the closing bell. Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX™, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 2/15/2006 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured: Genomic Health, Inc. [GHDX] rings the Closing Bell. These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.